With the Patient Assistance Program from AbbVie, you can receive up to 12 months of medication at no cost to you if you are approved. You can also reapply as needed.
Popular offers
Mounjaro
4 pens of 2.5mg/0.5ml 1 carton
$1,274.00
As low as $995.00
Wegovy
4 prefilled 0.25mg pens of 0.25mg/0.5ml 1 carton
$1,641.60
As low as $0.00
Ozempic
1 prefilled 2mg pen of 2mg/3ml 1 carton
$1,291.67
As low as $25.00
Zepbound
4 prefilled pens of 2.5mg/0.5ml 1 carton
$1,281.02
As low as $25.00
Atorvastatin
40mg 30 tablets
As low as $7.74
Receive your prescription at no cost to you if you are eligible.
Less expensive drugs that work the same way may be available.
Pay as little as
Per 30-day or 90-day fill*
With the FETZIMA Savings Program you may be eligible to get a 30-or 90-day fill for as little as $10
This offer is available to patients with commercial insurance coverage and a valid FETZIMA prescription. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs
*Not available to all U.S. patients. Restrictions apply. See Terms and Conditions link below for full eligibility requirements.
IMPORTANT SAFETY INFORMATION
FETZIMA may cause serious side effects, including:
Increased risk of suicidal thoughts and actions. FETZIMA and other antidepressant medicines may increase suicidal thoughts and actions in some people 24 years and younger, especially within the first few months of treatment or when the dose is changed. FETZIMA is not for use in children.
Depression or other mental illnesses are the most important causes of suicidal thoughts or actions.
Pay close attention to any changes, especially sudden changes in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. This is very important when an antidepressant medicine is started or when the dose is changed.
Call your healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings or if you develop suicidal thoughts or actions.
Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
Call your healthcare provider or get emergency medical help right away if you or your family member has any of these symptoms, especially if they are new, worse, or worry you:
Attempts to commit suicide; acting on dangerous impulses; acting aggressive; being angry or violent; thoughts about suicide or dying; new or worsening depression or anxiety; feeling very agitated or restless; panic attacks; trouble sleeping; new or worsening irritability; an extreme increase in activity or talking (mania); or other unusual changes in behavior or mood.
FETZIMA may cause serious side effects, including:
Serotonin syndrome. A potentially life-threatening problem called serotonin syndrome can happen when FETZIMA is taken with certain other medicines. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the following signs and symptoms of serotonin syndrome: agitation, confusion, fast heartbeat, dizziness, flushing, tremors, stiff muscles or muscle twitching, seizures, seeing or hearing things that are not real (hallucinations), coma, blood pressure changes, sweating, high body temperature (hyperthermia), loss of coordination, nausea, vomiting, or diarrhea.
High blood pressure (hypertension). Your healthcare provider should check your blood pressure before you start and during treatment with FETZIMA. If you have high blood pressure, it should be controlled before you start treatment with FETZIMA.
Increased heart rate. Your healthcare provider should check your heart rate before you start and during treatment with FETZIMA. If you have heart problems or problems with an abnormal heartbeat, your problems should be treated before you start treatment with FETZIMA.
Increased risk of bleeding. Taking FETZIMA with aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin, or blood thinners may add to this risk. Tell your healthcare provider right away about any unusual bleeding or bruising.
Eye problems (angle-closure glaucoma). FETZIMA may cause a type of eye problem called angle-closure glaucoma in people with certain eye problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are. Call your healthcare provider if you have changes in your vision, eye pain, or swelling or redness in or around the eye.
Problems with urination. FETZIMA may cause you to have problems with urination, including decreased urine flow and being unable to pass any urine. Tell your healthcare provider if you develop any problems with urine flow during treatment with FETZIMA.
Manic episodes. Manic episodes may happen in people with bipolar disorder who take FETZIMA. Symptoms may include greatly increased energy, racing thoughts, unusually grand ideas, talking more or faster than usual, severe trouble sleeping, reckless behavior, or excessive happiness or irritability.
Seizures (convulsions).
Discontinuation symptoms. Suddenly stopping FETZIMA may cause you to have serious side effects. Your healthcare provider may want to decrease your dose slowly. Symptoms may include changes in your mood, irritability and agitation, dizziness, electric shock sensation (paresthesia), anxiety, confusion, headache, tiredness, problems sleeping, hypomania, ringing in your ears (tinnitus), and seizures.
Low sodium levels in the blood (hyponatremia). Low sodium levels in your blood that may be serious and may cause death can happen during treatment with FETZIMA. Elderly people and people who take certain medicines may be at greater risk for this. Symptoms may include headache, difficulty concentrating, memory changes, confusion, weakness, and unsteadiness on your feet, which can lead to falls. In more severe or more sudden cases, signs and symptoms include hallucinations (seeing or hearing things that are not real), fainting, seizures, coma, and stopping breathing (respiratory arrest).
Sexual problems. Taking FETZIMA may cause sexual problems. Talk to your healthcare provider if you develop any changes in your sexual function or if you have any questions or concerns about sexual problems during treatment.
DO NOT take FETZIMA if you:
are allergic to levomilnacipran, milnacipran HCl, or any of the ingredients in FETZIMA
are taking, or have taken within the last 14 days, medications called monoamine oxidase inhibitors (MAOIs) for a psychiatric illness
are being treated with other types of MAOIs, including the antibiotic linezolid or intravenous methylene blue
Do not start taking an MAOI for at least 7 days after you stop treatment with FETZIMA.
Before taking FETZIMA, tell your healthcare provider if you:
have or had a family history of suicide, depression, bipolar disorder, mania, or hypomania
have high blood pressure
have or had heart problems, including a fast heartbeat, or stroke
have or had bleeding problems
have glaucoma (high pressure in the eye)
have or had problems urinating (hesitating) or emptying your bladder (retention)
have or had seizures (convulsions)
have low sodium levels in your blood
have or had kidney problems
drink alcohol
are pregnant or plan to become pregnant. FETZIMA may harm your unborn baby. Taking FETZIMA during your third trimester of pregnancy may cause an increased risk of bleeding after delivery and may cause your baby to be at increased risk for withdrawal symptoms, or breathing, temperature control, feeding, or other problems at birth. Talk to your healthcare provider about the risks to you and your baby if you take FETZIMA during pregnancy.
Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with FETZIMA.
There is a pregnancy registry for females who are exposed to FETZIMA during pregnancy. The purpose of the registry is to collect information about the health of females exposed to FETZIMA and their babies. If you become pregnant during treatment with FETZIMA, you are encouraged to register with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/research/pregnancyregistry/antidepressants
are breastfeeding or plan to breastfeed. It is not known if FETZIMA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with FETZIMA.
If you breastfeed during treatment with FETZIMA, call your healthcare provider right away if your baby develops sleepiness or fussiness, or is not feeding or gaining weight well.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
FETZIMA and other medicines may affect each other, causing possible serious side effects.
FETZIMA may affect the way other medicines work, and other medicines may affect the way FETZIMA works.
Especially tell your healthcare provider if you take:
MAOIs
medicines used to treat migraine headaches known as triptans
tricyclic antidepressants
lithium
tramadol, fentanyl, meperidine, methadone, or other opioids
tryptophan
buspirone
amphetamines
St. John's Wort
medicines used to treat mood, anxiety, psychotic or thought disorders, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)
medicines that can affect blood clotting, such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and warfarin
diuretics
Ask your healthcare provider if you are not sure if you are taking any of these medicines. Do not start or stop any other medicines during treatment with FETZIMA without talking to your healthcare provider first. Stopping FETZIMA suddenly may cause you to have serious side effects.
Avoid drinking alcohol during treatment with FETZIMA.
Do not drive, operate heavy machinery, or do other dangerous activities until you know how FETZIMA affects you. FETZIMA can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly.
The most common side effects of FETZIMA include:
nausea, vomiting, constipation, sweating, palpitations, fast or increased heart rate, erectile dysfunction, and ejaculation disorder
INDICATION AND LIMITATION OF USE
FETZIMA® (levomilnacipran), extended-release capsules, is a prescription medicine used to treat a certain type of depression called Major Depressive Disorder (MDD) in adults.
It is not known if FETZIMA is safe and effective for use in children.
FETZIMA is not for use for the management of fibromyalgia, and its efficacy and safety have not been established for that use.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of FETZIMA. For more information, ask your healthcare provider or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see full Prescribing Information, including Boxed Warning and Medication Guide or visit https://www.rxabbvie.com/pdf/fetzima_pi.pdf.
